Structural studies with novel ruthenium anticancer agents.
In this study, we aim to obtain the crystal structure of the ruthenium based anticancer agents which will provide us a better understand on the drug’s mechanism of action. Two ruthenium based drugs, RuCl2(η6-p-cymene)-(PTA), (PTA = 1,3,5-triaza-7-phosphaadamantane) or RAPTA-C and Hind[trans-RuCl4(in...
Saved in:
Main Author: | Soon, Cin Huang. |
---|---|
Other Authors: | Curtis Alexander Davey |
Format: | Final Year Project |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/39540 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Structural studies of the nucleosome, assembled with different histones, DNA fragments and HMGN proteins, and derivatized with ruthenium anticancer agents
by: Reyhan Muhammad
Published: (2013) -
Investigation of anticancer agent and high mobility group N protein binding to nucleosomes.
by: Ong, Michelle Shuling.
Published: (2010) -
Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
by: Davey, Curt Alexander, et al.
Published: (2018) -
Repurposing the anticancer drug cisplatin with the aim of developing novel
Pseudomonas aeruginosa
infection control agents
by: Yuan, Mingjun, et al.
Published: (2019) -
Characterizing the nucleosome site selectivity, adduct structures and impact on chromatin for a variety of metal-based anticancer compounds and structural studies of nucleosome-linker histone interactions
by: Adhireksan, Zenita
Published: (2016)